ClinicalTrials.Veeva

Menu

Anti-obesity Effect of Koji-extracted Beverage Fermented With Pediococcus Pentosaceus LP28

H

Hiroshima University

Status

Completed

Conditions

Overweight

Treatments

Dietary Supplement: Koji-extracted beverage fermented with Pediococcus pentosaceus LP28
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT02050555
eki-867

Details and patient eligibility

About

This study is designed to evaluate the effect of koji-extracted beverage fermented with Pediococcus pentosaceus LP28 on BMI and body fat in overweight subjects.

Enrollment

50 estimated patients

Sex

All

Ages

20 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • BMI 25-30 kg/m2

Exclusion criteria

  • Taking drugs or functional food that may affect body weight or body fat
  • Pregnant or nursing a child
  • Participation in any clinical trial within 90 days of the commencement of the trial
  • Renal or hepatic dysfunction
  • Heart disease
  • History of severe disease and/or major surgery

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

50 participants in 2 patient groups, including a placebo group

Koji-extracted beverage
Placebo Comparator group
Description:
100ml/day for 12 weeks
Treatment:
Dietary Supplement: Placebo
Koji-extracted beverage fermented with LP28
Experimental group
Description:
100ml/day for 12 weeks. 1x10\^11 cells (LP28)/day
Treatment:
Dietary Supplement: Koji-extracted beverage fermented with Pediococcus pentosaceus LP28

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems